Dialog Box


ACCESSING MEDICINES and Clinical Trials in Australia

Accessing Cancer Medicines in Australia


Pharmaceutical company Bristol-Myers Squibb has developed a new guide to access to cancer medicine in Australia. The guide includes information on what it takes to get a new cancer medicine from discovery to patients, and informatioon on how medicines are regulated in Australia. There is also a clear explanation on avenues to explore to access new medicines before they are registered on the PBS or approved by the TGA. 

Download or read the pdfs.

Short form.

Long form.


Clinical Trials


A clinical trial is a research study that helps to determine whether a new drug or device is safe and/or effective. Each study is designed to answer questions and find better ways to screen, diagnose, prevent or treat a disease or condition. They may be sponsored by pharmaceutical companies, the government or other organisations.

All brain tumour trials registered in Australia can be accessed by searching the Australian Cancer Trials Website or the ANZ Clinical Trials Register. 


The Cancer Council Victoria has an easy to use trial search facility here.


Thie Australian Clinical trials website contains links to other websites which have listings of clinical trials and is searchable by disease or keyword.

Some trials might be at a pre-registration stage, some open and some closed.


The first website above is derived from entries in the US clinicaltrials.gov website and the ANZCTR website. You can also independently go to the US website http://clinicaltrials.gov/ct2/search/advanced and enter the words "brain tumours" and "Australia" (no quotation marks) in the relevant search boxes.

This is a link to the (Australian) Cooperative Trials Group for Neuro-Oncology (COGNO). According to its website "COGNO's main aim is to conduct investigator initiated and collaborative group trials addressing important clinical questions in patients with brain tumours." The use of the words "investigator initiated" in the context of clinical trials implies that they have not been initiated by pharmaceutical companies.


Knowledge about the status of available trials tends to be passed by word of mouth among oncologists, so you should also ask if your oncologist is planning to be involved in any trials or knows of centres which will be involved. Ask your oncologist about your suitablity for any current or emerging trials.


Professor Ben Williams - a 21-year glioblastoma survivor - has published a free update to his book: “Surviving Terminal Cancer”. Originally published in 2002, he offers free updates that include the latest research and treatment developments from a US perspective. Download it or read online here.

MoST @ Garvan Sydney UPDATED June 2017

The Molecular Screening and Therapeutics (MoST) Program informaton sheet for doctors is available here. About MoST here.

Doctors should review this document and assess if their patients fulfill standard clinical trial entry criteria required for participation. Referral letters can be sent to most@garvan.org.au or faed to +61 2 9355 5872. Once referral documents are received you will be contacted to make an appointment.  

BTAA list clinical trial information here as they come to our attention as a public service only. Talk to your health professionals about options available to you.